280 related articles for article (PubMed ID: 29654751)
41. Administration of depot medroxyprogesterone acetate on the day of mifepristone for medical abortion: a pilot study.
Sonalkar S; McClusky J; Hou MY; Borgatta L
Contraception; 2015 Feb; 91(2):174-7. PubMed ID: 25481376
[TBL] [Abstract][Full Text] [Related]
42. Adolescent and Youth Experiences With Contraceptive Self-Injection in Uganda: Results From the Uganda Self-Injection Best Practices Project.
Corneliess C; Cover J; Secor A; Namagembe A; Walugembe F
J Adolesc Health; 2023 Jan; 72(1):80-87. PubMed ID: 36243559
[TBL] [Abstract][Full Text] [Related]
43. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
Polaneczky M; Guarnaccia M; Alon J; Wiley J
Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283
[TBL] [Abstract][Full Text] [Related]
44. Compliance with depot medroxyprogesterone acetate: a randomized, controlled trial of intensive reminders.
Keder LM; Rulin MC; Gruss J
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):583-5. PubMed ID: 9757955
[TBL] [Abstract][Full Text] [Related]
45. Acceptability of Contraceptive Self-Injection with DMPA-SC Among Adolescents in Gulu District, Uganda.
Cover J; Lim J; Namagembe A; Tumusiime J; Drake JK; Cox CM
Int Perspect Sex Reprod Health; 2017 Dec; 43(4):153-162. PubMed ID: 29771679
[TBL] [Abstract][Full Text] [Related]
46. Self-administration of injectable contraception: a systematic review and meta-analysis.
Kennedy CE; Yeh PT; Gaffield ML; Brady M; Narasimhan M
BMJ Glob Health; 2019; 4(2):e001350. PubMed ID: 31179026
[TBL] [Abstract][Full Text] [Related]
47. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
48. Factors affecting continuation rates of DMPA.
Hubacher D; Goco N; Gonzalez B; Taylor D
Contraception; 1999 Dec; 60(6):345-51. PubMed ID: 10715369
[TBL] [Abstract][Full Text] [Related]
49. Pharmacist-administered subcutaneous depot medroxyprogesterone acetate: a pilot randomized controlled trial.
Picardo C; Ferreri S
Contraception; 2010 Aug; 82(2):160-7. PubMed ID: 20654757
[TBL] [Abstract][Full Text] [Related]
50. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
Lei ZW; Wu SC; Garceau RJ; Jiang S; Yang QZ; Wang WL; Vander Meulen TC
Contraception; 1996 Jun; 53(6):357-61. PubMed ID: 8773423
[TBL] [Abstract][Full Text] [Related]
51. Combination injectable contraceptives for contraception.
Gallo MF; Grimes DA; Lopez LM; Schulz KF; d'Arcangues C
Cochrane Database Syst Rev; 2013; 3():CD004568. PubMed ID: 23641480
[TBL] [Abstract][Full Text] [Related]
52. What Distinguishes Women Who Choose to Self-Inject? A Prospective Cohort Study of Subcutaneous Depot Medroxyprogesterone Acetate Users in Ghana.
Nai D; Tobey E; Fuseini K; Kuma-Aboagye P; Jain A
Glob Health Sci Pract; 2022 Feb; 10(1):. PubMed ID: 35294390
[TBL] [Abstract][Full Text] [Related]
53. Operational assessments of Sayana® Press provision in Senegal and Uganda.
Cover J; Blanton E; Ndiaye D; Walugembe F; Lamontagne DS
Contraception; 2014 May; 89(5):374-8. PubMed ID: 24565737
[TBL] [Abstract][Full Text] [Related]
54. Contraceptive injections by community health workers in Uganda: a nonrandomized community trial.
Stanback J; Mbonye AK; Bekiita M
Bull World Health Organ; 2007 Oct; 85(10):768-73. PubMed ID: 18038058
[TBL] [Abstract][Full Text] [Related]
55. Ugandan providers' views on the acceptability of contraceptive self-injection for adolescents: a qualitative study.
Cover J; Namagembe A; Tumusiime J; Lim J; Cox CM
Reprod Health; 2018 Oct; 15(1):165. PubMed ID: 30285779
[TBL] [Abstract][Full Text] [Related]
56. Contraceptive efficacy and safety of DMPA-SC.
Jain J; Jakimiuk AJ; Bode FR; Ross D; Kaunitz AM
Contraception; 2004 Oct; 70(4):269-75. PubMed ID: 15451329
[TBL] [Abstract][Full Text] [Related]
57. Home-based administration of Sayana® Press: review and assessment of needs in low-resource settings.
Keith B; Wood S; Tifft S; Hutchings J
Contraception; 2014 May; 89(5):344-51. PubMed ID: 24813924
[TBL] [Abstract][Full Text] [Related]
58. Combination injectable contraceptives for contraception.
Gallo MF; Grimes DA; Lopez LM; Schulz KF; d'Arcangues C
Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD004568. PubMed ID: 18843662
[TBL] [Abstract][Full Text] [Related]
59. Update to U.S. Selected Practice Recommendations for Contraceptive Use: Self-Administration of Subcutaneous Depot Medroxyprogesterone Acetate.
Curtis KM; Nguyen A; Reeves JA; Clark EA; Folger SG; Whiteman MK
MMWR Morb Mortal Wkly Rep; 2021 May; 70(20):739-743. PubMed ID: 34014910
[TBL] [Abstract][Full Text] [Related]
60. Would you be interested in DMPA-SC? An implementation project in two urban primary care clinics.
Miles C; Ennamuri D; Yeh J; Shih G
Contraception; 2022 Aug; 112():116-119. PubMed ID: 35123982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
